| Identification | |
| Name: | Atazanavir sulfate |
| Synonyms: | 2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt);methyl N-[(1S)-1-[[[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-4-phenyl-butyl]-[(4-pyridin-2-ylphenyl)methyl]amino]carbamoyl]-2,2-dimethyl-propyl]carbamate; sulfuric acid;Reyataz (*1:1 sulfate*);BMS-232632-05;Latazanavir;BMS-232632;methyl N-[(1S)-1-[[[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-4-phenyl-butyl]-[(4-pyridin-2-ylphenyl)methyl]amino]carbamoyl]-2,2-dimethyl-propyl]carbamate;Atazanavir sulfate (JAN/USAN);CGP-73547;Reyataz (TN);(2S)-N-(3-{[(2S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoylamino][(4-(2-pyridyl)phenyl)methyl]amino}(1S,2S)-2-hydroxy-1-benzylpropyl)-2-(methoxycarbonylamino)-3,3-dimethylbutanamide;Atazanavir sulfate [USAN];Zrivada; |
| CAS: | 229975-97-7 |
| Molecular Formula: | C38H52N6O7.H2SO4 |
| Molecular Weight: | 802.93 |
| InChI: | InChI=1/C38H52N6O7.H2O4S/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28;1-5(2,3)4/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47);(H2,1,2,3,4)/t29-,30-,31+,32+;/m0./s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.164g/cm3 |
| Specification: |
Atazanavir sulfate , with CAS number of 229975-97-7, can be called 2,5,6,10,13-Pentaazatetradecanedioic acid, 3-12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((-4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, |
| Safety Data | |
 |
|
